Hodgkin's disease: A population-adjusted clinical epidemiology study (PACE) of management at presentation

QJM: An International Journal of Medicine

Volumn 91, Issue 2, 1998, Pages 131-139

  Taylor, P R A ^a   Angus, B ^a   Owen, J P ^a   Proctor, S J ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER STAGING; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 0031891342     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Taylor PRA, Reid MM, Stark AN, Bown N, Hamilton PJ, Proctor SJ, on behalf of the Northern Region Haematology Group. De-novo acute myeloid leukaemia in patients over 55 years old. A population based study of incidence, treatment and outcome. Leukemia 1995; 9:231.
2. Proctor SJ, Taylor PRA, Stark A, Carey PJ, Bown N, Hamilton PJ, Reid MM, on behalf of the Northern Regional Haematology Croup. Evaluation of the impact of allogeneic transplant in first remission on an unselected population of patients with acute myeloid leukaemia aged 15-55 years. Leukemia 1995; 9:1246.
3. Taylor PRA, Reid MM, Bown N, Hamilton PJ, Proctor SJ, on behalf of the Northern Region Haematology Group. Acute lymphoblastic leukemia in patients aged sixty years and over: a population based study of incidence and outcome. Blood 1992; 80:1813.
4. Charlton B, Taylor PRA, Proctor SJ. The PACE strategy: a new approach to multicentre clinical research. QJM 1997; 90:147.
5. Lukes RJ, Butler JJ. The Pathology and nomenclature of Hodgkin's Disease. Can Res 1996; 26:1063.
6. Lister TA, Crowther D, Sutcliffe SB, Glatstein E, Canellos GP, Young RC, Rosenberg SA, Coltman CA, Tubiana M. Report of a Committee Convened to Discuss the Evaluation and Staging of Patients with Hodgkin's Disease: Cotswolds Meeting. J Clin Oncol 1989; 7:1630.
7. Royal College of Radiologists. The use of Computed Tomography in the Initial Investigation of Common Malignancies. 1994.
8. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the committee on Hodgkin's disease staging. Can Res 1971; 31:1860.
9. Proctor SJ, Taylor P, Mackie MJ, Donnan P, Boys R, Lennard A, Prescott RJ, with Members of the Scotland and Newcastle Lymphoma Group (SNLG) Therapy Working Party. A numerical prognostic index for clinical use in identification of poor-risk patients with Hodgkin's disease at diagnosis. Leukemia Lymphoma 1992; 7(Suppl):17.
10. Leukaemia and Lymphoma: an atlas of distribution within areas of England and Wales (1984-1988). 1990:83.
11. Keller AR, Kaplan HS, Lukes RJ, Rappart H. Correlation of histopathology with other prognostic indictors in Hodgkin's Disease. Cancer 1968; 22:487.
12. Bernhards J, Fischer R, Hubner K, Schwarze E-W, Georgii A. Histopathological classification of Hodgkin's lymphomas. Ann Oncol 1992; 3:31.
13. Tesch H, Hasenclever D, von Wasielewski R, Fischer R, Hubner K, Hansmann ML, Bernards J, Sextro M, Franklin J, Diehl V, Georgii A. Impact of histopathology on survival and relapse of patients with Hodgkin's disease. Results from the German Hodgkin Study Group. Ann Oncol 1996; 7:49.
14. Sextro M, Diehl V, Franklin J, Hansmann ML, Anagnostopoulos I, Marafioti T, Stein H. Lymphocyte predominant Hodgkin's disease - a workshop report. European Task Force on Lymphoma. Ann Oncol 1996; 7:61.
15. McIntyre EA. The use of monoclonal antibodies for purging autologous bone marrow in the lymphoid malignancies. In Goldstone AH, ed. Clinics in Haematology, WB Saunders, 1986:249.
16. Milligan DW, Howard MR, Judd A. Premedication with Lorazepam before bone marrow biopsy. J Clin Path 1987; 40:696.
17. Bartl R, Frisch B, Burkhardt R, Huhn D, Pappenberger R. Assessment of bone marrow histology in Hodgkin's disease: correlation with clinical factors. Br J Haematol 1997; 51:345.
18. Rosenberg SA. The management of Hodgkin's disease: half a century of change. The Kaplan Memorial Lecture. Ann Oncol 1996; 7:555.
19. Kennedy BJ, Loeb V, Peterson VM, Donegan WL, Natarajan N, Mettlin C. National survey of patterns of care for Hodgkin's disease. Cancer 1985; 56:2547.
20. Enblad G, Glimelius B, Sundström C. Treatment outcome in Hodgkin's disease in patients above the age of 60: a population-based study. Ann Oncol 1991; 2:297.
21. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996; 276:637.
22. Peto R. Clinical Trial reporting. Lancet 1996; 348:894.
23. Bartlett NL, Rosenberg SA, Hoppe RT, Hancock SL, Horning SJ. Brief chemotherapy, Stanford V, and adjunct Radiotherapy for bulky advanced-stage Hodgkin's Disease: A preliminary report. J Clin Oncol 1995; 13:1080.